clinical trials for glp 1 The GLP-1 Trial Landscape in 2024 Orforglipron, an Oral Small-Molecule GLP-1

Description

This can result in better management of blood sugar levels and reduced insulin resistance

Clinical evidence from randomized trials and associated meta-analysis suggest thyroid cancer as a rare event making effect estimates imprecise but without conclusive and consistent evidence of increase risk in those receiving GLP-1 RA

Timestamped Show Notes [00:00:00] Introduction - Brittany's home office with plants and dogs [02:02] The "holistic" medicine debate [04:02] Why Brittany opened Sweetgrass Psychiatry [07:00] Bringing family medicine in-house [10:01] The economics of integrating primary care [11:08] Scaling to 30 clinicians [13:41] Full suite of interventional services offered [15:08] Nine out of twenty patients on GLP-1s [16:15] Depression and metabolic syndrome: 50/50 overlap [19:03] GLP-1s and the mesolimbic system [20:24] JAMA Psychiatry study on semaglutide for alcohol use disorder [21:17] Dr